Cortalix

Groningen, Netherlands · Founded 2023 · Privately Held (backing)

Developer of a biotechnological platform designed for single-domain antibody (sdAb) discovery and development. Cortalix is based in Groningen, Netherlands and was founded in 2023. It has raised $1.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$1.3M
Last round
—
Valuation — not yet established

No valuation for Cortalix is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($1.3M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cortalix with a free account
  • ·Watch Cortalix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cortalix funding history

No rounds on record

No funding rounds for Cortalix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Cortalix's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cortalix, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Cortalix

How much has Cortalix raised?
Cortalix has raised $1.3M in total funding across its recorded rounds.